118 related articles for article (PubMed ID: 8399783)
1. A new look at the limits of detection (LD), quantification (LQ) and power of definition (PD).
Gautschi K; Keller B; Keller H; Pei P; Vonderschmitt DJ
Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):433-40. PubMed ID: 8399783
[TBL] [Abstract][Full Text] [Related]
2. Variance function as basis for assessment of test performance: methodological studies with two assays of prostate-specific antigen.
Hänseler E; Keller B; Keller H
Clin Chem; 1994 Nov; 40(11 Pt 1):2046-52. PubMed ID: 7525116
[TBL] [Abstract][Full Text] [Related]
3. Performance profiles: new tools for characterization and comparison of clinical chemical results.
Keller H; Passing H
J Clin Chem Clin Biochem; 1989 Sep; 27(9):613-29. PubMed ID: 2607322
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of cocaine metabolite screening in view of the analytical performance of a fluorescence polarisation immunoassay.
Hänseler E; Keller H
Eur J Clin Chem Clin Biochem; 1994 Nov; 32(11):865-71. PubMed ID: 7888483
[TBL] [Abstract][Full Text] [Related]
5. Estimation of the lower limits of manual and automated platelet counting.
Hänseler E; Fehr J; Keller H
Am J Clin Pathol; 1996 Jun; 105(6):782-7. PubMed ID: 8659455
[TBL] [Abstract][Full Text] [Related]
6. Error models for immunoassays.
Sadler WA
Ann Clin Biochem; 2008 Sep; 45(Pt 5):481-5. PubMed ID: 18753420
[TBL] [Abstract][Full Text] [Related]
7. A new mathematical procedure for the assessment of test performance of PSA assays.
Hänseler E; Keller H
Scand J Clin Lab Invest Suppl; 1995; 221():52-6. PubMed ID: 7544485
[TBL] [Abstract][Full Text] [Related]
8. [Measuring cyclosporine levels in whole blood in kidney transplantation].
Bottini PV; Alves-Cunha FA; Moda MA; Souza MI; Garlipp CR
Rev Assoc Med Bras (1992); 1998; 44(3):176-8. PubMed ID: 9755544
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine A monitoring in patients with renal, cardiac, and liver transplants: a comparison between fluorescence polarization immunoassay and two different RIA methods.
Bergan S; Rugstad HE; Stokke O; Bentdal O; Frøysaker T; Bergan A
Scand J Clin Lab Invest; 1993 Aug; 53(5):471-7. PubMed ID: 8210969
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of the cyclosporine parent-compound-specific whole blood TDx assay.
Pescovitz MD; Book BK; Pollard SG; Milgrom ML; Leapman SB; Filo RS
Clin Transplant; 1992 Feb; 6(1):43-7. PubMed ID: 10147649
[TBL] [Abstract][Full Text] [Related]
11. Estimating imprecision profiles in biochemical analysis.
Berweger CD; Müller-Plathe F; Hänseler E; Keller H
Clin Chim Acta; 1998 Oct; 277(2):107-25. PubMed ID: 9853695
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the AxSYM monoclonal cyclosporin assay and comparison with radioimmunoassay.
Sabaté I; Ginard M; González JM; Baró E; Acebes G; Cuadros J; Lirón FJ
Ther Drug Monit; 2000 Aug; 22(4):474-80. PubMed ID: 10942190
[TBL] [Abstract][Full Text] [Related]
13. Monitoring cyclosporin A (ciclosporin, INN) concentrations in whole blood: evaluation of the EMIT assay in comparison with HPLC and RIA.
Schumann G; Petersen D; Hoyer PF; Wonigeit K
Eur J Clin Chem Clin Biochem; 1993 Jun; 31(6):381-8. PubMed ID: 8369366
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a monoclonal antibody fluorescent polarization immunoassay with monoclonal antibody radioimmunoassay for cyclosporin determination in whole blood.
Alvarez JS; Sacristan JA; Alsar MJ
Ther Drug Monit; 1992 Feb; 14(1):78-80. PubMed ID: 1546394
[TBL] [Abstract][Full Text] [Related]
15. Determination of a two-tailed 100(1-alpha)% upper limit on the relative error in the laboratory-to-laboratory standard deviation obtained from an interlaboratory study.
McClure FD; Lee JK
J AOAC Int; 2009; 92(5):1593-601. PubMed ID: 19916398
[TBL] [Abstract][Full Text] [Related]
16. Using the variance function to estimate limit of blank, limit of detection and their confidence intervals.
Sadler WA
Ann Clin Biochem; 2016 Jan; 53(Pt 1):141-9. PubMed ID: 25678668
[TBL] [Abstract][Full Text] [Related]
17. A review of troponin assay performance in Wales: can the same (method-dependent) decision limits be used in different sites?
Thomas MA; Singh GK; Williams EJ; McDowell IF; Tovey JA; Wayte AM;
Ann Clin Biochem; 2005 Sep; 42(Pt 5):351-6. PubMed ID: 16168190
[TBL] [Abstract][Full Text] [Related]
18. Validating precision--how many measurements do we need?
ÅSberg A; Solem KB; Mikkelsen G
Scand J Clin Lab Invest; 2015 Oct; 75(6):496-9. PubMed ID: 26083607
[TBL] [Abstract][Full Text] [Related]
19. Progress report of an external quality assessment scheme for cyclosporine assay.
Zucchelli GC; Pilo A; Chiesa MR; Scarlattini M; Bizollon CA
Ther Drug Monit; 1996 Jun; 18(3):273-9. PubMed ID: 8738767
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cyclosporin G (Nva2-cyclosporin) concentrations measured in whole blood by monoclonal fluorescence polarization immunoassay, monoclonal radioimmunoassay, and HPLC.
Annesley TM; Coombs RC; Orsulak PJ
Clin Chem; 1993 Jun; 39(6):1050-3. PubMed ID: 8504536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
